1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Vietnam Pharmaceuticals and Healthcare Report Q3 2016

Vietnam Pharmaceuticals and Healthcare Report Q3 2016

  • July 2016
  • -
  • Business Monitor International
  • -
  • 107 pages

BMI View:

Leveraging Vietnam's National Expanded Immunisation Programme (EPI) will be of strategic benefit to multinational pharmaceutical firms with a strong vaccines portfolio. Government support for the initiative is expected to remain strong, which bodes well for firms as the EPI alleviates financial barriers that might dissuade patients from receiving treatment. A key risk to this approach stems from potential protectionist measures implemented by the Vietnamese government as it seeks to encourage the inclusion of locally produced vaccines.

Headline Expenditure Projections
- Pharmaceuticals: VND92.5trn (USD4.2bn) in 2015 to VND105.6trn (USD4.6bn) in 2016; +14.2% in local currency terms and +9.3% in US dollar terms. Forecast virtually unchanged from last quarter.
- Healthcare: VND304.3trn (USD13.9bn) in 2015 to VND333.4bn (USD14.6bn) in 2016; +9.6% in local currency terms and +4.9% in US dollar terms. Forecast increased compared to the previous quarter.

Table Of Contents

Vietnam Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View ... 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Vietnam 2014-2020) . 7
SWOT 9
Industry Forecast .. 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Vietnam 2012-2020) 13
Healthcare Market Forecast .. 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Vietnam 2012-2020) . 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Vietnam 2012-2020) . 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Vietnam 2012-2020) . 19
Prescription Drug Market Forecast 20
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Vietnam 2012-2020) . 22
Patented Drug Market Forecast . 23
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Vietnam 2012-2020) . 24
Generic Drug Market Forecast .. 25
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Vietnam 2012-2020) 26
OTC Medicine Forecast 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Vietnam 2012-2020) . 29
Pharmaceutical Trade Forecast . 30
Table: Pharmaceutical Trade Data And Forecasts (Vietnam 2014-2020) . 32
Table: Pharmaceutical Trade Data And Forecasts local currency (Vietnam 2014-2020) . 32
Pharmaceuticals and Healthcare Risk/Reward Index ... 33
Asia Pacific Risk/Reward Index - Q3 2016 33
Vietnam Risk/Reward Index ... 39
Rewards .. 39
Risks .. 39
Regulatory Review 41
Intellectual Property Issues 43
Table: Special 301 Submission: Issues Raised For Vietnam . 44
Pricing Regime .. 47
Reimbursement Regime .. 52
Market Overview ... 56
Healthcare Sector .. 57
Table: Healthcare Resources (Vietnam 2010-2015) 60
Table: Healthcare Personnel (Vietnam 2010-2015) 60
Table: Healthcare Activity (Vietnam 2010-2015) 61
Research and Development 66
Competitive Landscape 76
Research-Based Industry . 76
Table: Multinational Market Activity . 80
Pharmaceutical Distribution 81
Pharmaceutical Retail Sector ... 81
Table: Key Aspects Of Good Pharmacy Practice In Developing Countries . 83
Company Profile 84
DHG Pharmaceutical ... 84
GlaxoSmithKline . 86
Sanofi 88
Traphaco Pharmaceutical . 91
Vietnam Pharmaceutical Corporation (Vinapharm) ... 93
Demographic Forecast . 96
Table: Population Headline Indicators (Vietnam 1990-2025) . 97
Table: Key Population Ratios (Vietnam 1990-2025) . 97
Table: Urban/Rural Population and Life Expectancy (Vietnam 1990-2025) 98
Table: Population By Age Group (Vietnam 1990-2025) . 98
Table: Population By Age Group % (Vietnam 1990-2025) 99
Glossary ... 101
Methodology 103
Pharmaceutical Expenditure Forecast Model 103
Healthcare Expenditure Forecast Model ... 103
Notes On Methodology .. 104
Risk/Reward Index Methodology . 105
Index Overview 106
Table: Pharmaceutical Risk/Reward Index Indicators 106
Indicator Weightings 107

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.